According to BioNexus Gene Lab's latest financial reports the company's current revenue (TTM) is $9.77 M. In 2022 the company made a revenue of $10.92 M a decrease over the years 2021 revenue that were of $13.36 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $10.33 M | -5.41% |
2022 | $10.92 M | -18.21% |
2021 | $13.36 M | -28.25% |
2020 | $18.62 M | 14570.54% |
2019 | $0.12 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |